GMO is a company that provides investment insights and strategies to help clients meet their financial goals.

For more than 40 years, GMO has partnered with a broad range of sophisticated institutions, financial intermediaries, and families to provide the investment expertise they need to meet their goals and fulfill their missions.

Investing on behalf of our clients is GMO’s sole focus. Across asset classes and around the world, our investment teams identify and exploit long-term opportunities and develop solutions that both anticipate and respond to client needs.

GMO is comprised of a collection of investment teams with focused specialties. All are grounded in a long-term, valuation-based investment philosophy – an approach we believe provides the best risk-adjusted returns.

GMO partners with an impressive roster of sophisticated clients worldwide, delivering innovative investment solutions and tailored client service. Our clients benefit from our diverse expertise, intellectual curiosity, and open culture of debate, as well as from our ability and willingness to take advantage of contrarian market opportunities. 

For important disclosure information please visit:  https://www.gmo.com/americas/terms-and-conditions/

GMO’s first ETF, U.S. Quality (NYSE: QLTY), recently surpassed $500 million in assets since launching in November 2023!

We've been thrilled with the warm welcome QLTY has received in the ETF marketplace. We believe high-quality stocks should be a core allocation in portfolios, and we're excited to see that so many ETF investors agree! 

Learn more about QLTY: https://bit.ly/3Wl8F43

GMO’s Rachna Ramachandran, Portfolio Manager for GMO’s High Yield Strategy, was a panelist at the Fixed Income Leaders Summit last week in Boston. Rachna shared her insights on the attractiveness of the High Yield space today and expectations for 2024.

Learn more about GMO’s approach to High Yield here: https://ow.ly/9UAY50SlbFg

We recently hosted a live webinar with GMO’s Small Cap Quality portfolio managers, Hassan Chowdhry and James Mendelson; they shared why small cap valuations are attractive today and how a quality approach to the asset class can generate superior risk-adjusted returns.

GMO is proud to sponsor Girls on the Run Greater Boston, one of our partners through our employee-led Charitable Giving Program. Girls on the Run Greater Boston's mission is to inspire girls in grades 3-8 to be joyful, healthy, and confident through a creative afterschool curriculum integrating running. The Greater Boston chapter serves communities throughout Eastern Massachusetts.

On June 1st, Girls on the Run Greater Boston hosted the Spring Season Celebratory 5K in East Boston. Thank you to all fellow sponsors, participants, and volunteers! We are proud to partner with Girls on the Run Greater Boston!

GMO is proud to stand with and celebrate our LGBTQ+ community this Pride Month.

At GMO we pride ourselves on recognizing and celebrating what is unique in each of us.  We are committed to fostering an environment that celebrates and respects differences and is diverse in thought, knowledge, and experience. We know our team is stronger and delivers the best results when we can each bring our full, authentic selves to work in service to our clients, each other, and our communities. 

This June at GMO our Diversity, Equity and Inclusion Group will be hosting events for our employees to learn from, affirm and celebrate our LGBTQ+ colleagues and to recognize and support the greater LGBTQ+ community.

Happy Pride!

#Pride2024 #DEI

GMO’s Quality Fund was a top winner in Investor's Business Daily's 2024 Best Mutual Funds Awards in the Best Large-Cap Funds category. Congratulations to Tom Hancock and the Focused Equity team!

"It's quality at a reasonable price," Tom Hancock said. "So in terms of the consistency of performance, I think that's been very important." 

Investor's Business Daily Business Daily spotlighted the GMO Quality Fund and the fund’s 10-year track record here: https://ow.ly/GaLk50RZ4cs

View the full list of winners: https://ow.ly/GOcN50RZ4cu

For more information including risks and a current prospectus please click here: https://ow.ly/yvjM50RZ4ct

COM:GMO

GMO

Analysis Not Available